Clinical Trial Update: Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes [Phase 1, Phase 2]

View source ↗

Summary

This release provides a trial update on a melanoma vaccine being tested in Stage III melanoma patients after lymph node surgery (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melanoma vaccine

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: UNKNOWN